COSCIENS Biopharma Inc. Current Assets
COSCIENS Biopharma Inc. (CSCIF) had Current Assets of $11.50 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-03-25
- 2025-12-31: Current Assets $11.50M.
- 2025-09-30: Current Assets $13.84M.
- 2025-06-30: Current Assets $16.50M.
- 2025-03-31: Current Assets $20.35M.
| Period end | Current Assets | Current Assets as first filed |
|---|---|---|
| 2025-12-31 | $11.50M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $13.84M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $16.50M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $20.35M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $23.98M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $28.22M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $33.21M 6-K · filed 2024-08-13 | |
| 2024-03-31 | $31.20M 6-K · filed 2024-05-16 | |
| 2023-12-31 | $11.27M 20-F · filed 2025-04-09 | $36.37M 20-F · filed 2024-03-27 |
| 2023-09-30 | $41.91M 6-K · filed 2023-11-09 | |
| 2023-06-30 | $45.89M 6-K · filed 2023-08-09 | |
| 2023-03-31 | $50.71M 6-K · filed 2023-05-09 | |
| 2022-12-31 | $55.49M 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $58.61M 6-K · filed 2022-11-03 | |
| 2022-06-30 | $63.17M 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $67.10M 6-K · filed 2022-05-11 | |
| 2021-12-31 | $70.82M 20-F/A · filed 2024-02-15 | |
| 2021-09-30 | $72.40M 6-K · filed 2021-11-04 | |
| 2021-06-30 | $74.73M 6-K · filed 2021-08-05 | |
| 2021-03-31 | $77.56M 6-K · filed 2021-05-05 | |
| 2020-12-31 | $27.61M 20-F · filed 2022-03-29 | $27.89M 40-F · filed 2021-03-25 |
| 2020-09-30 | $23.32M 6-K · filed 2020-11-05 | |
| 2020-06-30 | $9.05M 6-K · filed 2020-08-06 | |
| 2020-03-31 | $11.05M 6-K/A · filed 2020-05-11 | |
| 2019-12-31 | $10.91M 40-F/A · filed 2021-03-29 | |
| 2019-09-30 | $12.79M 6-K · filed 2019-11-07 | |
| 2019-06-30 | $11.77M 6-K · filed 2019-08-13 | |
| 2018-12-31 | $16.26M 20-F · filed 2020-03-31 | |
| 2017-12-31 | $9.38M 20-F · filed 2019-04-01 | |
| 2016-12-31 | $22.74M 20-F · filed 2018-03-28 |